Liquid chromatography‐tandem mass spectrometric determination of propofol in rat serum and hair at attogram level after derivatization with 3‐bromomethyl‐propyphenazone

HIGHLIGHTSDerivatization of propofol with 3‐bromomethyl‐propyphenazone followed by LVC/MS analysis.The derivatized propofol was detectable at attogram level in hair and serum.The LLOQ was 0.01 pg/mL serum (equivalent to 50 ag/&mgr;L in injectable solution).The ionization suppression was minimized by deactivating the excess reagent with methanol.The concentration patterns of propofol in rat serum and hair were unmatched. ABSTRACT A sensitive, selective and precise liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method for determination of propofol (PRO) in rat serum and hair has been developed. 3‐Bromomethyl‐propyphenazone was used as derivatization reagent forming propofol‐methyl‐propyphenazone compound. The derivatization reaction was optimized and validated for maximum MS sensitivity. The MS instrumental sensitivity reached to 10 attogram. The serum samples were extracted by using Chromabond C8 columns, while hair samples extracted with methanol. The tendency of volatility of PRO was minimized by adding triethylamine to the extract before the use of nitrogen gas for evaporation of solvent. The limit of quantitation (LLOQ) was 0.01 pg/mL and the assay was linear to 10000 pg/mL. The intra‐and inter‐day precision (RSD%) ranged from 0.33 to 3.44% while the accuracy (Er%, relative error) were −6.4 to 1.1%. The ionization suppression, due to reagent, was minimized by reacting the excess reagent with methanol, and eluting to waste before MS ionization source (2–4.5 min). The method was successfully applied for detection and determination of PRO in rat serum and hair after 7–28 days from administration of only one dose of propofol (10 mg/kg).

[1]  Sean C. Sweetman,et al.  Martindale: The Complete Drug Reference , 1999 .

[2]  D. Kim Propofol use for sedation or sedation for propofol use? , 2012, Journal of Anesthesia.

[3]  F. Busardò,et al.  Enhancing the sensitivity of the LC-MS/MS detection of propofol in urine and blood by azo-coupling derivatization , 2014, Analytical and Bioanalytical Chemistry.

[4]  A. Khedr,et al.  3-Bromomethyl-propyphenazone as a new derivatization reagent for high performance liquid chromatography of captopril and hydrochlorothiazide with UV-detection. , 1998, Biomedical chromatography : BMC.

[5]  E. Caravati,et al.  The abuse potential of propofol , 2010, Clinical toxicology.

[6]  Bradley R. Johnson,et al.  A Survey of Propofol Abuse in Academic Anesthesia Programs , 2007, Anesthesia and analgesia.

[7]  J. Marier,et al.  Development of a rapid and sensitive LC-ESI/MS/MS assay for the quantification of propofol using a simple off-line dansyl chloride derivatization reaction to enhance signal intensity. , 2005, Journal of pharmaceutical and biomedical analysis.

[8]  John H. Block,et al.  Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry , 1991 .

[9]  Jae Il Lee,et al.  Rapid and sensitive determination of propofol glucuronide in hair by liquid chromatography and tandem mass spectrometry. , 2013, Journal of pharmaceutical and biomedical analysis.

[10]  A. Schmoldt,et al.  Death after excessive propofol abuse , 2001, International Journal of Legal Medicine.

[11]  F. Pragst,et al.  State of the art in hair analysis for detection of drug and alcohol abuse. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[12]  AC Moffat,et al.  Clarke's analysis of drugs and poisons , 2003 .

[13]  W. Mapleson,et al.  Tissue/blood and tissue/water partition coefficients for propofol in sheep. , 2001, British journal of anaesthesia.

[14]  G. Schelling,et al.  Formation of the N-methylpyridinium ether derivative of propofol to improve sensitivity, specificity and reproducibility of its detection in blood by liquid chromatography-mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  P. du Souich,et al.  In vivo and in vitro effect of cimetidine, inflammation, and hypoxia on propofol kinetics. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[16]  Laurent Galichet,et al.  Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material , 2004 .

[17]  P. Hartvig,et al.  Clinical pharmacokinetics of propofol given as a constant-rate infusion and in combination with epidural blockade. , 1994, Journal of clinical anesthesia.